Date Presented 03/28/20
Our longitudinal study is exploring the feasibility and reliability of using actigraphy as a meaningful outcome measure in children ages four through seven involved in a clinical trial. Our data examine activity levels and sleep patterns in boys with DMD in their natural environment throughout the drug trial. We hypothesize that using activity monitoring as an outcome measure will provide a meaningful view of daytime and nighttime activity for these young boys to show treatment effect.
Primary Author and Speaker: Natalie Silverman
Contributing Authors: Michelle Beck, Danielle Hall, Amy Hartman, Roxanna Bendixen